Have any thoughts about
Linc AB?
Write Note

Linc AB
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Linc AB
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Linc AB
STO:LINC
Cash Equivalents
kr520m
CAGR 3-Years
187%
CAGR 5-Years
71%
CAGR 10-Years
N/A
R
Ratos AB
STO:RATO B
Cash Equivalents
kr2.4B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
EQT AB
STO:EQT
Cash Equivalents
€1.1B
CAGR 3-Years
8%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Bure Equity AB
STO:BURE
Cash Equivalents
kr892m
CAGR 3-Years
23%
CAGR 5-Years
1%
CAGR 10-Years
21%
Catella AB
STO:CAT B
Cash Equivalents
kr796m
CAGR 3-Years
-19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Traction AB
STO:TRAC B
Cash Equivalents
kr305.7m
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

Linc AB
Glance View

Market Cap
4.9B SEK
Industry
Financial Services

Linc AB is an investment company that focuses on long-term share ownership in the Nordic life science market. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2021-05-28. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The firm works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.

LINC Intrinsic Value
130.44 SEK
Undervaluation 35%
Intrinsic Value
Price

See Also

What is Linc AB's Cash Equivalents?
Cash Equivalents
520m SEK

Based on the financial report for Dec 31, 2023, Linc AB's Cash Equivalents amounts to 520m SEK.

What is Linc AB's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
71%

Over the last year, the Cash Equivalents growth was -13%. The average annual Cash Equivalents growth rates for Linc AB have been 187% over the past three years , 71% over the past five years .

Back to Top